Breakthrough Respiration Treatment to Be Used on Critically Ill COVID-19 Patients
By HospiMedica International staff writers Posted on 19 Feb 2021 |
Image: The AXT system (Photo courtesy of Inspira Technologies)
A breakthrough respiratory support system that directly oxygenates blood and immediately elevates and stabilizes patient oxygen levels will be used on critically ill COVID-19 patients.
The intensive care unit (ICU) of the Department of Cardiac Surgery at Sheba Medical Center (Tel Aviv, Israel) will test the innovative Augmented Respiration Technology (ART) from Inspira Technologies (Ra'anana, Israel) on severely ill COVID-19 patients. ART is the world's first technology to oxygenate blood directly as a first line support. It uniquely fills a gap in respiratory treatment where supplemental respiratory therapies such as high-pressure masks are insufficient and the risks from mechanical ventilation - such as medically-induced comas, intubation, and lung atrophy - are unjustified. The ART system is an alternative to highly invasive mechanical ventilation systems, preventing the need for medically induced comas and intubation. The technology solution lowers the risks and costs of existing ventilation systems by allowing patients to remain awake and mobile during treatment, and the simple system design allows for broader medical use.
“We are very excited to test this breakthrough technology for respiratory distress,” said Dr. Alexander Kogan, Director of the Cardiac Surgery ICU at Sheba's Heart Center. “With the ART system, hopefully, patients will remain fully conscious during their treatment. We will be able to avoid the use of mechanical ventilation until it's absolutely necessary and spare many patients from the risks of a medically-induced coma. Moreover, we anticipate further development of our novel renal replacement therapy technology for these critically ill patients with the help of Inspira.”
“Collaborating with the Sheba Medical Center is a great opportunity to test the ART system in a real-world environment and demonstrate its ease of use for medical staff and effectiveness for treating patients,” added Dagi Ben-Noon, co-founder and CEO of Inspira.
Related Links:
Inspira Technologies
Sheba Medical Center
The intensive care unit (ICU) of the Department of Cardiac Surgery at Sheba Medical Center (Tel Aviv, Israel) will test the innovative Augmented Respiration Technology (ART) from Inspira Technologies (Ra'anana, Israel) on severely ill COVID-19 patients. ART is the world's first technology to oxygenate blood directly as a first line support. It uniquely fills a gap in respiratory treatment where supplemental respiratory therapies such as high-pressure masks are insufficient and the risks from mechanical ventilation - such as medically-induced comas, intubation, and lung atrophy - are unjustified. The ART system is an alternative to highly invasive mechanical ventilation systems, preventing the need for medically induced comas and intubation. The technology solution lowers the risks and costs of existing ventilation systems by allowing patients to remain awake and mobile during treatment, and the simple system design allows for broader medical use.
“We are very excited to test this breakthrough technology for respiratory distress,” said Dr. Alexander Kogan, Director of the Cardiac Surgery ICU at Sheba's Heart Center. “With the ART system, hopefully, patients will remain fully conscious during their treatment. We will be able to avoid the use of mechanical ventilation until it's absolutely necessary and spare many patients from the risks of a medically-induced coma. Moreover, we anticipate further development of our novel renal replacement therapy technology for these critically ill patients with the help of Inspira.”
“Collaborating with the Sheba Medical Center is a great opportunity to test the ART system in a real-world environment and demonstrate its ease of use for medical staff and effectiveness for treating patients,” added Dagi Ben-Noon, co-founder and CEO of Inspira.
Related Links:
Inspira Technologies
Sheba Medical Center
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans